Division of Vascular Diseases and Surgery, Department of Surgery, Wexner Medical Center, The Ohio State University, Columbus, Ohio.
Division of Hematology, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, Ohio.
J Vasc Surg Venous Lymphat Disord. 2018 Sep;6(5):575-583.e1. doi: 10.1016/j.jvsv.2017.12.059. Epub 2018 Jun 23.
The role of follow-up venous duplex ultrasound (DUS) after acute lower extremity deep vein thrombosis (DVT) remains unclear, yet it is commonly performed. We aimed to clarify the role of follow-up DUS. Our primary objective was to determine the association between the presence of residual venous obstruction (RVO) on DUS and DVT recurrence or propagation (rDVT). Secondary objectives included finding risk factors associated with RVO and rDVT.
We conducted a retrospective study of patients diagnosed with DVT on DUS from January 1, 2011, to December 31, 2013, that received a follow-up DUS. Patient demographics, risk factors, medications, and DUS findings were recorded. Ten segments from the common femoral to distal calf veins were checked for the presence of RVO, DVT propagation, and recurrence. RVO was defined as any nonacute venous obstruction with more than 40% of luminal diameter remaining during compression or the presence of chronic post-thrombotic occlusive disease. rDVT was measured as either a new acute DVT in the previously involved segment, or involvement of a new segment in the same extremity.
A total of 185 lower extremities representing 156 patients met the inclusion criteria. RVO was noted in 61.1% of limbs. The 3-year rDVT rate was 10.3%. Patients with recurrent venous thromboembolism or thrombophilia had a higher risk of developing RVO (odds ratio [OR], 2.89, P < .01; OR, 4.39, P = .04, respectively). Extremities with larger clot burden had an increased risk of RVO on follow-up DUS (OR, 1.25 per segment; P < .01). The presence and degree of RVO on follow-up DUS had an increased risk of rDVT on subsequent DUS (OR, 3.90, P = .04; OR, 1.21 per segment, P = .04, respectively). Limbs with complete resolution of DVT by DUS had a significantly decreased risk of rDVT (OR, 0.26; P = .04).
Extremities with larger initial clot burden exhibited an increased risk of subsequent RVO. The presence of RVO and, interestingly, the number of involved segments on follow-up DUS increased the risk of rDVT. Our results suggest that the presence of residual disease and increased RVO burden on follow-up DUS after an acute DVT may identify those patients who are at an increased risk for rDVT and may help guide the duration of anticoagulation therapy.
急性下肢深静脉血栓形成(DVT)后随访静脉双功能超声(DUS)的作用仍不清楚,但临床上常进行该检查。本研究旨在阐明随访 DUS 的作用。我们的主要目的是确定 DUS 上残余静脉阻塞(RVO)与 DVT 复发或进展(rDVT)之间的关系。次要目标包括寻找与 RVO 和 rDVT 相关的危险因素。
我们对 2011 年 1 月 1 日至 2013 年 12 月 31 日期间因 DVT 行 DUS 诊断并接受随访 DUS 的患者进行了回顾性研究。记录患者的人口统计学、危险因素、药物使用情况和 DUS 检查结果。对从股总静脉到小腿远端的 10 个节段进行检查,以确定是否存在 RVO、DVT 进展和复发。RVO 定义为任何非急性静脉阻塞,在压迫时管腔直径仍有超过 40%的残余或存在慢性血栓后闭塞性疾病。rDVT 定义为先前受累节段出现新的急性 DVT,或同一肢体出现新的节段受累。
共纳入 185 条下肢 156 例患者,其中 61.1%的肢体存在 RVO。3 年 rDVT 发生率为 10.3%。复发性静脉血栓栓塞或血栓形成患者发生 RVO 的风险更高(比值比 [OR],2.89,P<.01;OR,4.39,P=.04)。随访 DUS 上存在较大血栓负荷的肢体 RVO 的风险增加(OR,每节段增加 1.25;P<.01)。随访 DUS 上 RVO 的存在和严重程度增加了随后发生 rDVT 的风险(OR,3.90,P=.04;OR,每节段增加 1.21,P=.04)。DUS 完全溶解 DVT 的肢体 rDVT 风险显著降低(OR,0.26;P=.04)。
初始血栓负荷较大的肢体发生后续 RVO 的风险增加。急性 DVT 后随访 DUS 上存在 RVO 且受累节段数增加,rDVT 的风险增加。我们的结果表明,急性 DVT 后随访 DUS 上存在残余疾病和 RVO 负荷增加可能会识别出那些 rDVT 风险增加的患者,并可能有助于指导抗凝治疗的持续时间。